Third quarter 2017 reported net sales of $1.1 billion declined 3.3%
on an as reported basis compared to the third quarter 2016

Third quarter 2017 volume points of 1.3 billion declined 5.6%
compared to the third quarter 2016

FY '17 reported and adjusted1 diluted EPS
guidance narrowed to ranges of $3.90 to $4.10 and $4.42 to $4.62,
respectively, from the previous ranges of $3.80 to $4.20 and $4.30 to
$4.70, respectively

Initial full year 2018 volume point guidance range of 2% to 6%
growth and initial full year 2018 GAAP diluted and adjusted1
diluted EPS guidance ranges of $3.82 to $4.22 and $4.60 to $5.00,
respectively

Since February 2017, the Company has repurchased a total of
approximately $757 million of common stock and has approximately $743
million remaining under the current repurchase authorization

"During this year of transition, we believe our performance has now
stabilized and we are seeing improvements in trends," said Rich Goudis,
CEO of Herbalife. "By continuing to implement our strategic plan, we
expect to build on the improving trends and return to growth in 2018."

For the third quarter 2017, the company reported net sales of $1.1
billion, which represents a decline of 3.3% and 4.0% on an as reported
and constant currency basis, respectively, compared to the third quarter
2016.

Third quarter 2017 volume points of 1.3 billion declined 5.6% compared
to the prior year period.

On a reported basis, third quarter 2017 net income was $54.5 million, or
$0.66 per diluted share, compared to third quarter 2016 net income of
$87.7 million, or $1.01 per diluted share.

Adjusted1 earnings for the third quarter 2017 was $0.82 per
diluted share compared to $1.21 per diluted share for the third quarter
of 2016.

For the full year 2017, the company is narrowing its 2017 reported and
adjusted1 diluted EPS guidance to ranges of $3.90 to $4.10
and $4.42 to $4.62, respectively, from the previous ranges of $3.80 to
$4.20 and $4.30 to $4.70, respectively.

For the full year 2018, the company is providing initial volume guidance
in the range of 2% to 6% growth and initial full year 2018 GAAP diluted
and adjusted1 diluted EPS guidance in the range of $3.82 to
$4.22 and $4.60 to $5.00, respectively.

Third Quarter 2017 Key Metrics2

Regional Volume Point Metrics

Volume Points (Mil)

Region

3Q '17

Yr/Yr % Chg

North America

261.5

-16.1

%

Asia Pacific

278.7

1.0

%

EMEA

258.9

2.7

%

Mexico

213.3

-9.0

%

South & Central America

150.2

-6.8

%

China

147.8

-3.5

%

Worldwide Total

1,310.4

-5.6

%

Regional Net Sales and Foreign Exchange ("FX") Impact

Reported Net Sales

Growth/Decline

Growth/Decline

Region

3Q '17 (mil)

including FX

excluding FX

North America

$

199.8

-17.1

%

-17.2

%

Asia Pacific

$

230.9

-0.2

%

-0.5

%

EMEA

$

213.9

6.1

%

2.0

%

Mexico

$

114.3

1.3

%

-3.6

%

South & Central America

$

116.7

-3.6

%

1.5

%

China

$

209.8

-2.1

%

-2.0

%

Worldwide Total

$

1,085.4

-3.3

%

-4.0

%

Outlook

Based on current business trends the company's fourth quarter 2017, full
year 2017, and full year 2018 guidance are as follows:

Three Months Ending

Twelve Months Ending

December 31, 2017

December 31, 2017

Low

High

Low

High

Volume Point Growth vs 2016

(4.0

%)

1.0

%

(4.2

%)

(2.9

%)

Net Sales Growth vs 2016

2.3

%

7.3

%

(1.9

%)

(0.6

%)

Diluted EPS (a)

$

0.64

$

0.84

$

3.90

$

4.10

Adjusted Diluted EPS (a) (b)

$

0.84

$

1.04

$

4.42

$

4.62

Cap Ex ($ millions)

$

20.0

$

40.0

$

88.0

$

108.0

Effective Tax Rate (a)

30.0

%

36.0

%

24.4

%

25.9

%

Adjusted Effective Tax Rate (a) (b)

27.0

%

33.0

%

22.1

%

23.6

%

Currency Adjusted Net Sales Growth vs 2016

(0.7

%)

4.3

%

(2.1

%)

(0.8

%)

Currency Adjusted Diluted EPS

$

0.80

$

1.00

$

4.62

$

4.82

Twelve Months Ending

December 31, 2018

Low

High

Volume Point Growth vs 2017

2.0

%

6.0

%

Net Sales Growth vs 2017

5.5

%

9.5

%

Diluted EPS (a)

$

3.82

$

4.22

Adjusted Diluted EPS (a) (b)

$

4.60

$

5.00

Cap Ex ($ millions)

$

115.0

$

155.0

Effective Tax Rate (a)

29.0

%

33.0

%

Adjusted Effective Tax Rate (a) (b)

26.0

%

30.0

%

Currency Adjusted Net Sales Growth vs 2017

4.3

%

8.3

%

Currency Adjusted Diluted EPS

$

4.50

$

4.90

(a) Excludes any future potential ongoing tax effects
from the exercise of equity awards that could impact the company's
tax rate due to the updated stock compensation accounting standard.

(b) Adjusted diluted EPS and adjusted effective tax rate,
for the purposes of guidance, excludes the impact of expenses
relating to challenges to the company's business model, the impact
of non-cash interest costs associated with the company's convertible
notes, benefits from future potential China grants, FTC settlement
implementation and expenses related to regulatory inquiries, as
applicable and detailed in Schedule A. See Schedule A -
"Reconciliation of Non-GAAP Financial Measures" for a detailed
reconciliation of adjusted diluted EPS to diluted EPS calculated in
accordance with GAAP and a discussion of why the company believe
these non-GAAP measures are useful.

With respect to guidance, the company cannot accurately predict the
impact to its share base from any future repurchases in 2017 and 2018
that may be made under its share repurchase program and therefore the
guidance table above excludes any impact thereof to EPS. Guidance
includes the impact of the recently completed tender offer.

Guidance is based on the average daily exchange rates during the first
two weeks of October.

Adjusted1 diluted EPS guidance for the fourth quarter 2017
includes a projected currency benefit of approximately $0.04 per diluted
share versus the fourth quarter of 2016.

Full year 2017 adjusted1 diluted EPS guidance includes a
projected currency headwind of approximately $0.20 per diluted share,
compared to 2016, which is consistent with the headwind included in the
updated guidance the company provided on August 1, 2017.

Full year 2018 adjusted1 diluted EPS guidance includes a
projected currency benefit of approximately $0.10 per diluted share,
compared to 2017.

Third Quarter 2017 Earnings Conference Call

Herbalife senior management will host an investor conference call to
discuss its recent financial results and provide an update on current
business trends on Thursday, November 2, 2017, at 2:30 p.m. PT (5:30
p.m. ET).

The dial-in number for this conference call for domestic callers is
(877) 317-1296, and (262) 320-2006 for international callers (conference
ID 34074913). Live audio of the conference call will be simultaneously
webcast in the investor relations section of the company's website at http://ir.herbalife.com.

An audio replay will be available following the completion of the
conference call in MP3 format or by dialing (855) 859-2056 for domestic
callers or (404) 537-3406 for international callers (conference ID
34074913). The webcast of the teleconference will be archived and
available on Herbalife's website.

About Herbalife Ltd.

Herbalife is a global nutrition company that has been changing people's
lives with great products since 1980. Our nutrition, weight-management,
energy and fitness and personal care products are available
exclusively to and through dedicated Herbalife Independent Members in
more than 90 countries. We are committed to fighting the worldwide
problems of poor nutrition and obesity by offering high-quality
products, one-on-one coaching with an Herbalife Member and a community
that inspires customers to live a healthy, active life.

We support the Herbalife Family Foundation (HFF) and its Casa
Herbalife programs to help bring good nutrition to children in need. We
also sponsor more than 190 world-class athletes, teams and events around
the globe, including Cristiano Ronaldo, the LA Galaxy and champions in
many other sports.

The company has over 8,000 employees worldwide, and its shares are
traded on the New York Stock Exchange (NYSE: HLF) with net sales of
approximately $4.5 billion in 2016. To learn more, visit Herbalife.com
or IAmHerbalife.com.

The Herbalife Investor Relations website at http://ir.herbalife.com
contains a significant amount of financial and other information about
the company. The company encourages investors to visit its website from
time to time, as information is updated and new information is posted.

______________________________________________________

1 Adjusted net income and adjusted diluted EPS are both
non-GAAP measures and, for the purposes of reported results and
guidance, exclude the impact of: expenses relating to challenges to the
company's business model, recovery of re-audit expenses, the impact of
non-cash interest costs associated with the company's convertible notes,
expenses relating to FTC settlement implementation, China grant income,
regulatory settlements and expenses related to regulatory inquiries, as
applicable and detailed in Schedule A. See Schedule A - "Reconciliation
of Non-GAAP Financial Measures" for a detailed reconciliation of
adjusted net income to net income calculated in accordance with GAAP and
a reconciliation of adjusted diluted EPS to diluted EPS calculated in
accordance with GAAP and a discussion of why we believe these non-GAAP
measures are useful.

2 Supplemental tables that include Average Active Sales
Leader and additional business metrics can be found at http://www.ir.herbalife.com.

FORWARD-LOOKING STATEMENTS

This release contains "forward-looking statements" within the meaning
of the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995.Although we believe that the expectations
reflected in any of our forward-looking statements are reasonable,
actual results could differ materially from those projected or assumed
in any of our forward-looking statements. Our future financial condition
and results of operations, as well as any forward-looking statements,
are subject to change and to inherent risks and uncertainties, such as
those disclosed or incorporated by reference in our filings with the
Securities and Exchange Commission. Important factors that could cause
our actual results, performance and achievements, or industry results to
differ materially from estimates or projections contained in our
forward-looking statements include, among others, the following:

regulatory matters governing our products, including potential
governmental or regulatory actions concerning the safety or efficacy
of our products and network marketing program, including the direct
selling markets in which we operate;

legal challenges to our network marketing program;

the consent order entered into with the FTC, the effects thereof and
any failure to comply therewith;

risks associated with operating internationally and the effect of
economic factors, including foreign exchange, inflation, disruptions
or conflicts with our third party importers, pricing and currency
devaluation risks, especially in countries such as Venezuela;

uncertainties relating to interpretation and enforcement of
legislation in China governing direct selling and anti-pyramiding;

our inability to obtain the necessary licenses to expand our direct
selling business in China;

adverse changes in the Chinese economy;

our dependence on increased penetration of existing markets;

any material disruption to our business caused by natural disasters,
other catastrophic events, acts of war or terrorism, or cyber-security
incidents;

We do not undertake any obligation to update or release any revisions
to any forward-looking statement or to report any events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events, except as required by law.

RESULTS OF OPERATIONS:

Herbalife Ltd. and Subsidiaries

Condensed Consolidated Statements of Income

(In millions, except per share amounts)

(Unaudited)

Three Months Ended

Nine Months Ended

9/30/2017

9/30/2016

9/30/2017

9/30/2016

North America

$

199.8

$

241.0

$

648.0

$

753.5

Mexico

114.3

112.8

334.7

341.8

South and Central America

116.7

121.0

349.1

367.9

EMEA

213.9

201.6

648.4

619.0

Asia Pacific

230.9

231.4

686.2

687.1

China

209.8

214.2

668.0

674.1

Worldwide Net Sales

1,085.4

1,122.0

3,334.4

3,443.4

Cost of Sales

215.4

209.1

638.8

658.5

Gross Profit

870.0

912.9

2,695.6

2,784.9

Royalty Overrides

310.1

320.3

944.1

968.9

Selling, General and Administrative Expenses (1)

445.2

441.3

1,327.0

1,545.2

Other Operating Income (2)

(4.6

)

(0.2

)

(43.5

)

(29.1

)

Operating Income

119.3

151.5

468.0

299.9

Interest Expense, net

38.4

22.1

106.5

70.1

Income Before Income Taxes

80.9

129.4

361.5

229.8

Income Taxes (3)

26.4

41.7

84.2

69.2

Net Income

$

54.5

$

87.7

$

277.3

$

160.6

Weighted Average Shares Outstanding:

Basic

79.6

83.1

81.4

83.0

Diluted

83.0

86.4

85.0

86.1

Earnings Per Share:

Basic

$

0.69

$

1.06

$

3.41

$

1.94

Diluted

$

0.66

$

1.01

$

3.26

$

1.87

(1) Selling, General and Administrative Expenses
includes $203 million related to regulatory settlements for the
nine months ended September 30, 2016.

(2) Other Operating Income relates to certain China grant
income.

(3) Includes the impact of excess tax benefit
recognized under ASU 2016-09 of $0.6 million and $26.4 million for
the three months and nine months ended September 30, 2017,
respectively.

In addition to its reported results and guidance calculated in
accordance with GAAP, the company has included in this release adjusted
net income and adjusted diluted EPS, performance measures that the
Securities and Exchange Commission defines as "non-GAAP financial
measures." Management believes that such non-GAAP financial measures,
when read in conjunction with the company's reported or forecasted
results, in each case calculated in accordance with GAAP, can provide
useful supplemental information for investors because they facilitate a
period to period comparative assessment of the company's operating
performance relative to its performance based on reported or forecasted
results under GAAP, while isolating the effects of some items that vary
from period to period without any correlation to core operating
performance and eliminate certain charges that management believes do
not reflect the company's operations and underlying operational
performance. The company's definition of adjusted net income and
adjusted diluted earnings per share may not be comparable to similarly
titled measures used by other companies because other companies may not
calculate them in the same manner as the company does and should not be
viewed in isolation from nor as alternatives to net income or diluted
EPS calculated in accordance with GAAP.

The following is a reconciliation of net income, presented and reported
in accordance with U.S. generally accepted accounting principles, to net
income adjusted for certain items:

Three Months Ended

Nine Months Ended

9/30/2017

9/30/2016

9/30/2017

9/30/2016

(in millions)

Net income, as reported

$

54.5

$

87.7

$

277.3

$

160.6

Expenses incurred responding to attacks on the company's business
model (1) (2)

The following is a reconciliation of diluted earnings per share,
presented and reported in accordance with U.S. generally accepted
accounting principles, to diluted earnings per share adjusted for
certain items.

Three Months Ended

Nine Months Ended

9/30/2017

9/30/2016

9/30/2017

9/30/2016

(per share)

Diluted earnings per share, as reported

$

0.66

$

1.01

$

3.26

$

1.87

Expenses incurred responding to attacks on the company's business
model (1) (2)

(1) Based on interim income tax reporting rules, these
expenses are not considered discrete items. As a result, the
company's full year effective tax rate is impacted by these items.
When applying the full year effective tax rate to year-to-date
income, the company's year-to-date tax provision recorded with
respect to these non-GAAP adjustments is different from the
forecasted full-year tax provision impact of these items. As a
consequence, adjustments to the year-to-date and quarterly tax
impacts will be recorded as the adjusted full year effective tax
rate is applied to income in subsequent periods. Additionally,
adjustments to items unrelated to these non-GAAP adjustments may
have an effect on the income tax impact of these non-GAAP
adjustments in subsequent periods. The company plans to update the
income tax impact of these items in subsequent interim reporting
periods.

(2) Excludes tax (benefit)/expense as follows:

Three Months Ended

Nine Months Ended

9/30/2017

9/30/2016

9/30/2017

9/30/2016

(in millions)

Expenses incurred responding to attacks on the company's business
model

$

(0.2

)

$

(1.0

)

$

(1.0

)

$

(2.9

)

Expenses related to regulatory inquiries

(1.1

)

(1.6

)

(3.4

)

(5.3

)

Expenses incurred for the recovery of re-audit expenses

-

-

-

(1.0

)

Non-cash interest expense and amortization of non-cash issuance costs

(0.7

)

0.5

1.2

1.8

China grant income

1.5

-

12.7

8.4

FTC Consent Order Implementation

(1.1

)

(2.2

)

(5.6

)

(2.2

)

Regulatory settlements

-

(2.2

)

-

(68.7

)

Total income tax adjustments (5)

$

(1.6

)

$

(6.5

)

$

3.9

$

(69.9

)

Three Months Ended

Nine Months Ended

9/30/2017

9/30/2016

9/30/2017

9/30/2016

(per share)

Expenses incurred responding to attacks on the company's business
model

(4) Includes $3.0 million of product discounts related to
preferred member conversions for the nine months ended September 30,
2017.

(5) Amounts may not total due to rounding.

The following is a reconciliation of diluted earnings per share
guidance, presented in accordance with U.S. generally accepted
accounting principles, to adjusted diluted earnings per share guidance
for certain items.

Three Months Ending

Twelve Months Ending

December 31, 2017

December 31, 2017

Diluted EPS Guidance (1)

$0.64 - $0.84

$3.90 - $4.10

Expenses incurred responding to attacks on the company's business
model (2)

(4) Excludes tax impact of $5.6 million for the twelve
months ending December 31, 2017.

(5) Includes $3.0 million of product discounts related to
preferred member conversions for the twelve months ending December
31, 2017.

(6) Excludes tax impact of $0.8 million and $4.2 million
for the three and twelve months ending December 31, 2017,
respectively.

(7) Excludes tax impact of $12.7 million for the twelve
months ending December 31, 2017.

(8) Aggregates the individual tax impacts of each item as
described in greater detail in footnotes 2, 4, 6 and 7 above.

(9) Amounts may not total due to rounding.

The following is a reconciliation of diluted earnings per share
guidance, presented in accordance with U.S. generally accepted
accounting principles, to adjusted diluted earnings per share guidance
for certain items.

Twelve Months Ending

December 31, 2018

Diluted EPS Guidance (1)

$3.82 - $4.22

Expenses incurred responding to attacks on the company's business
model (2)